India-Based Dhiti Omics is Now Live on SOPHiA DDM™

July 4, 2024

https://www.prnewswire.com/news-releases/india-based-dhiti-omics-is-now-live-on-sophia-ddm-302189403.html

The diagnostics company has implemented the SOPHiA DDM™ Platform to enhance its solid tumor testing

BOSTON and ROLLE, Switzerland, July 4, 2024 /PRNewswire/ — SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that Dhiti Omics Technologies, a precision molecular diagnostics service provider in India, is live on the SOPHiA DDM™ Platform. The company will use SOPHiA GENETICS’ technology to enhance its solid tumor testing capabilities.

Read more at prnewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.